The first gene-silencing drug has won FDA approval. Patirisan treats a rare and sometimes fatal hereditary disease called ATTR by using RNA to turn off a mutated gene.

See the source article by following the link below:
The first gene-silencing drug has won FDA approval. Patirisan treats a rare and sometimes fatal hereditary disease called ATTR by using RNA to turn off a mutated gene.